U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. FDA Public Workshop: Partners in Progress 2018 - Cancer Patient Advocates and FDA - 11/27/2018
  1. Section N/A

Workshop | In Person

Event Title
FDA Public Workshop: Partners in Progress 2018 - Cancer Patient Advocates and FDA
November 27, 2018

Date:
November 27, 2018
Location:
Event Location
White Oak Campus: The Great Room
Conference Center

10903 New Hampshire Ave
Building 31, Room 1503
Silver Spring, MD 20993
United States


Organized By:
Organizer

The FDA Oncology Center of Excellence will hold its second annual educational workshop for new cancer patient advocates, Partners in Progress: Cancer Patient Advocates and FDA. The objectives are to provide basic training on the role of the FDA and cancer patient advocates in oncology product development. This broad introduction to FDA regulatory aspects of oncology product development is most relevant to attendees with limited knowledge and experience in cancer product development and patient advocacy.

FDA Campus Information, (e.g., local airports, directions, and local hotels)

The FDA does not provide travel scholarships to attendees of this meeting.

In-person attendees will receive complementary food and beverages provided by the Supporting Organizations:

  • Cancer Support Community
  • Leukemia and Lymphoma Society
  • Susan G. Komen

Webcast Information:

FDA archived webcast of this meeting is available as follows: 

Webcast/Adobe Connect:

Meeting Information:

Speakers Presentations:

Welcome

Session 1: Introduction to the Role of FDA

Session 2: How Patient Engages Engage 

Session 3: Oncology Center of Excellence’s (OCE) Outreach Efforts 

Session 4: Insights into Cancer Drug Development 

Session 5: A Patient-Centered Approach to Efficacy Outcomes 

Session 6: Updates from FDA Centers on Recent Cancer Product Approval

Contact:

Virginia (Gini) Kwitkowski, MS, ACNP-BC
Center for Drug Evaluation and Research
Office of New Drugs
Office of Hematology and Oncology Products
Virginia.Kwitkowski@fda.hhs.gov

Back to Top